Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Frailty is a significant problem in patients undergoing liver transplant and is associated with poor outcomes and survival. Hence, optimizing physical fitness and counteracting frailty is important. However, many interventions are very resource intensive and therefore not feasible.
In this study, the investigators aim to test the effectiveness of a newly designed intervention to improve frailty in liver transplant candidates. The "LIver FrailTy" intervention (LIFT) will consist of an evaluation by a physical therapist, an individualized home exercise prescription (HEP), exercise tracking using a smart phone application, daily text reminders to exercise and recurrent telephone check-ins.
Frailty is defined as a biologic syndrome of decreased physiologic reserve and increased vulnerability to health stressors. The concept of frailty has recently emerged as a critical determinant in the field of cirrhosis and liver transplantation. Frailty impacts pre- and post-transplant clinical outcomes, including waitlist mortality, post-transplant mortality, frequency of hospitalizations and duration of hospital admissions. Although the impact of frailty in liver transplantation has been established in the literature, there is a lack of data supporting effective interventions to decrease frailty prior to liver transplantation. Moreover, the studies that have tested interventions to improve physical function have relied on frequent supervised physical therapy (PT) sessions and access to exercise equipment that it is not financially or logistically feasible for the majority of patients. Patient engagement in PT also remains a critical barrier to overcome to decrease frailty in preparation for liver transplantation. Developing a practical and effective intervention to consistently engage patients in physical activity and decrease frailty is essential to improving clinical outcomes in the pre- and post-liver transplant setting.
The investigators goal is to pilot test a novel PT intervention to decrease frailty in pre-transplant patients. The investigators have designed a prototype "LIver FrailTy" intervention (LIFT) that includes: PT evaluation, an individualized home exercise prescription (HEP), daily text message reminders to exercise and weekly telephone check-ins with team members.
The central hypothesis is that the LIFT intervention will 1) improve adherence to recommended levels of exercise in end-stage liver disease 2) reduce pre-transplant frailty and 3) will improve pre- and post-transplant clinical outcomes.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| LIFT subgroup | Experimental | Physical Therapy (PT) evaluation, an individualized home exercise prescription (HEP), daily text message reminders to exercise and weekly telephone check-ins with team members. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| "LIver FrailTy" intervention (LIFT) | Behavioral | Novel physical therapy intervention to decrease frailty in pre-transplant patients |
|
| Measure | Description | Time Frame |
|---|---|---|
| Frailty | Frailty is described as a biologic syndrome of decreased physiologic reserve and increased vulnerability to health stressors. This outcome is measured by the Liver frailty index [LFI]. LFI is composed of 3 performance-based tests (grip strength, chair stands, and balance). Patients are classified using established cutoffs (frail: LFI ≥ 4.5, pre-frail: LFI 3.3-4.4, robust: LFI ≤ 3.2). Higher LFI scores indicate a higher degree of frailty. | Baseline and final frailty assessment (mean time from baseline to final frailty assessment was 216 (± 157) days) |
| Patient-reported Physical Function | Patient-reported physical quality of life was measured using a validated patient-reported outcome measure (Patient-Reported Outcomes Measurement Information System Physical Function [PROMIS-PF]) completed in clinic. Patient-reported physical function was measured using a validated patient-reported outcome measure: Patient-Reported Outcomes Measurement Information System Physical Function [PROMIS-PF] Version 2.0 - Short Form 8c. A higher PROMIS T-score represents more of the concept being measured. A score of 50 is the average for the United States general population with a standard deviation of 10. A Physical Function T-score of 60 is one SD better than average. By comparison, a Physical Function T-score of 40 is one SD worse than average. Physical Function T-Scores range from 20.3 to 60.1. | Baseline and final frailty assessment (mean time from baseline to final frailty assessment was 216 (± 157) days) |
| Exercise Adherence Rate | Data continuously collected via TrueCoach smart phone application to document adherence to exercise regimen. If patients are unable to appropriately track adherence on the smart phone application, this data will be collected at weekly videoconference/telephone check-ins detailed below. Exercise adherence rates are defined as the number of completed or attempted exercise days/total exercise days prescribed. Overall, patients were classified as adherent to the exercise regimen if their adherence rate was ≥ 75% and partially adherent if ≥ 50%. Patients were classified as non-adherent if their adherence rate was < 50%. The mean intervention rate was measured throughout the follow-up period (from enrollment to final assessment) - the mean follow-up time was 259 (±190) days. |
| Measure | Description | Time Frame |
|---|---|---|
| Clinical Outcomes - Liver Related Complications | Data collected from medical chart for liver related complications including but not limited to diagnosis of: ascites, hepatic encephalopathy, variceal bleeding, hepatorenal syndrome, hepatopulmonary syndrome, infection. | Throughout the follow-up period (mean follow-up time is 259 (±190) days) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Daniela Ladner, MD | Northwestern University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Northwestern Medicine | Chicago | Illinois | 60611 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 40131764 | Derived | Thuluvath AJ, Polineni P, Morrissey S, Belfanti K, Nizamuddin M, Siddiqui O, Daud A, Simpson DC, Levitsky J, Flores AM, Duarte-Rojo A, Ladner DP. Home-based LIver FrailTy Intervention (LIFT) in Transplant Candidates: A Feasibility Study. Transplantation. 2025 Apr 1;109(4):e202-e212. doi: 10.1097/TP.0000000000005263. Epub 2024 Nov 6. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The study team proposed to employ a "Realistic Effort Action Planning" (REAP) intervention, which is a form of personality-informed motivational interviewing, in a subset of patients to determine if this enhances the LIFT intervention. Due to funding and time restrictions, the study team was unable to employ this intervention and focused solely on the LIFT intervention. The record has been revised appropriately and these details have also been provided in the Limitations section.
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | LIFT Subgroup | PT evaluation, an individualized home exercise prescription (HEP), daily text message reminders to exercise and weekly telephone check-ins with team members. "LIver FrailTy" intervention (LIFT): Novel physical therapy intervention to decrease frailty in pre-transplant patients |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | LIFT Subgroup | PT evaluation, an individualized home exercise prescription (HEP), daily text message reminders to exercise and weekly telephone check-ins with team members. "LIver FrailTy" intervention (LIFT): Novel physical therapy intervention to decrease frailty in pre-transplant patients |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Frailty | Frailty is described as a biologic syndrome of decreased physiologic reserve and increased vulnerability to health stressors. This outcome is measured by the Liver frailty index [LFI]. LFI is composed of 3 performance-based tests (grip strength, chair stands, and balance). Patients are classified using established cutoffs (frail: LFI ≥ 4.5, pre-frail: LFI 3.3-4.4, robust: LFI ≤ 3.2). Higher LFI scores indicate a higher degree of frailty. | Posted | Mean | Standard Deviation | score on a scale | Baseline and final frailty assessment (mean time from baseline to final frailty assessment was 216 (± 157) days) |
|
Through study completion, the mean follow-up time was 259 (SD ± 190) days. Follow-up time was defined from enrollment to end event with censoring at loss to follow-up. Possible end events: 1) the physical therapist recommended supervised outpatient PT at a future clinic visit; 2) the patient experienced a significant adverse event directly related to exercise; 3) the patient was deemed not to be a transplant candidate for any reason; 4) the patient was transplanted or 5) the patient died.
Potential adverse events related to exercise or LFI measurement were assessed during biweekly telephone calls, clinic visits and remote LFI measurements. Patients were advised to notify the research team of any adverse events immediately. Potential adverse events of interest included physical injuries such as muscle strains, falls or new complications of portal hypertension (i.e., variceal gastro-intestinal bleeding).
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | LIFT Subgroup | PT evaluation, an individualized home exercise prescription (HEP), daily text message reminders to exercise and weekly telephone check-ins with team members. "LIver FrailTy" intervention (LIFT): Novel physical therapy intervention to decrease frailty in pre-transplant patients |
Not provided
Not provided
This study originally proposed another arm/intervention ("Realistic Effort Action Planning" (REAP), which is a form of personality-informed motivational interviewing) in a subset of patients to determine if this enhances the LIFT intervention. The study team did not have the resources, funding, or time during patient encounters to employ this intervention, and thus focused only on the LIFT intervention.
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Therese Banea | Northwestern University | 312-694-7993 | therese.banea@northwestern.edu |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Nov 9, 2021 | Mar 18, 2024 | Prot_SAP_000.pdf |
Not provided
| ID | Term |
|---|---|
| D000073496 | Frailty |
| D005355 | Fibrosis |
| ID | Term |
|---|---|
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 1 month and 3 months after Enrollment, throughout the follow-up period (mean follow-up time is 259 (±190) days) |
| years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Race/Ethnicity, Customized | Count of Participants | Participants |
|
| BMI | Mean | Standard Deviation | kg/m² |
|
| Comorbidities | Count of Participants | Participants |
|
| Beta-blocker prescribed | Count of Participants | Participants |
|
| Etiology of Liver Disease | Count of Participants | Participants |
|
| Decompensated | Count of Participants | Participants |
|
| Model for End-Stage Liver Disease Sodium Score (MELD-Na) | The Model for End-Stage Liver Disease - Sodium Score (MELD-Na) is a scoring system that helps measure severe liver disease, predicting how likely a patient is to die from liver disease within 3 months. The MELD-Na score is based on a patient's serum creatinine, international normalized ratio (INR), and bilirubin. The higher the MELD-Na Score, the higher risk of death and the more likely you are to receive a liver from a deceased donor when an organ becomes available. The MELD-Na score ranges from 6 (lower risk of death) to 40 (higher risk of death). | Mean | Standard Deviation | units on a scale |
|
| Baseline Liver Frailty Index | The Liver Frailty Index (LFI) is a validated measure of frailty in patients with cirrhosis, consisting of measurements of grip strength, chair stands, and balance. The higher the LFI score, the more frail the patient is. Patients are classified using established cutoffs (frail: LFI ≥ 4.5, pre-frail: LFI 3.3-4.4, robust: LFI ≤ 3.2). | Mean | Standard Deviation | units on a scale |
|
| Baseline Frailty Status by Liver Frailty Index | Count of Participants | Participants |
|
| Baseline Patient-Reported Physical Function T-score | Patient-reported physical function was measured using a validated patient-reported outcome measure: Patient-Reported Outcomes Measurement Information System Physical Function (PROMIS-PF) Version 2.0 - Short Form 8c. A higher PROMIS T-score represents more of the concept being measured. A score of 50 is the average for the United States general population with a standard deviation of 10. A Physical Function T-score of 60 is one SD better than average. By comparison, a Physical Function T-score of 40 is one SD worse than average. Physical Function T-Scores range from 20.3 to 60.1. | Mean | Standard Deviation | units on a scale |
|
|
|
| Primary | Patient-reported Physical Function | Patient-reported physical quality of life was measured using a validated patient-reported outcome measure (Patient-Reported Outcomes Measurement Information System Physical Function [PROMIS-PF]) completed in clinic. Patient-reported physical function was measured using a validated patient-reported outcome measure: Patient-Reported Outcomes Measurement Information System Physical Function [PROMIS-PF] Version 2.0 - Short Form 8c. A higher PROMIS T-score represents more of the concept being measured. A score of 50 is the average for the United States general population with a standard deviation of 10. A Physical Function T-score of 60 is one SD better than average. By comparison, a Physical Function T-score of 40 is one SD worse than average. Physical Function T-Scores range from 20.3 to 60.1. | Posted | Mean | Standard Deviation | score on a scale | Baseline and final frailty assessment (mean time from baseline to final frailty assessment was 216 (± 157) days) |
|
|
|
| Primary | Exercise Adherence Rate | Data continuously collected via TrueCoach smart phone application to document adherence to exercise regimen. If patients are unable to appropriately track adherence on the smart phone application, this data will be collected at weekly videoconference/telephone check-ins detailed below. Exercise adherence rates are defined as the number of completed or attempted exercise days/total exercise days prescribed. Overall, patients were classified as adherent to the exercise regimen if their adherence rate was ≥ 75% and partially adherent if ≥ 50%. Patients were classified as non-adherent if their adherence rate was < 50%. The mean intervention rate was measured throughout the follow-up period (from enrollment to final assessment) - the mean follow-up time was 259 (±190) days. | Posted | Mean | Full Range | percentage of exercise adherence | 1 month and 3 months after Enrollment, throughout the follow-up period (mean follow-up time is 259 (±190) days) |
|
|
|
| Secondary | Clinical Outcomes - Liver Related Complications | Data collected from medical chart for liver related complications including but not limited to diagnosis of: ascites, hepatic encephalopathy, variceal bleeding, hepatorenal syndrome, hepatopulmonary syndrome, infection. | No new liver related complications (e.g., new episodes of variceal bleeding) were reported because of the LIFT intervention during the follow-up period. | Posted | Count of Participants | Participants | Throughout the follow-up period (mean follow-up time is 259 (±190) days) |
|
|
|
| 0 |
| 81 |
| 0 |
| 81 |
| 0 |
| 81 |
Not provided
Not provided
Not provided
|